The global Pyrogen Testing market accounted for USD 785.2 Million in 2020 and is expected to reach USD 2,008.4 Million by 2028, growing at a CAGR of 12.4% from 2021 to 2028.
The global Pyrogen Testing Market accounted for USD 785.2 Million in 2020 and is expected to reach USD 2,008.4 Million by 2028, growing at a CAGR of 12.4% from 2021 to 2028.
Pyrogen testing is a critical step in ensuring the safety of parenteral pharmaceutical products and medical devices. It is part of the mandatory release tests to avoid life-threatening fever reactions induced by pyrogenic substances.
The players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development. Citing an instance, in May 2018, MilliporeSigma and Solvias decided to enter into collaboration for providing PyroMat System, an innovative monocyte activation test kit developed by both firms for Pyrogen detection, to customers.
The pandemic has led to increasing demand for drugs and APIs, those used against malaria are most in the demand, and then antibiotics and antivirals. The second wave of deficiency is observed among various diseases patients which are needed to care. As the pandemic progresses, the manufacturer of Pyrogen Testing works around the clock to ensure American patients have access to the drugs they need.
The covid-19 has created an opportunity for the number of patients as there is a high chance of adverse health effects of covid-19 on people. However, the covid-19 has positively impacted the Pyrogen Testing market.
The introduction of new drugs and the rise in the R&D activities witnessed across pharmaceutical and biotech sectors are anticipated to spur the Pyrogen testing market size over the coming years. Apart from this, massive funding for research & development activities pertaining to drug development along with favorable government policies stimulating the growth of Pharma & biotech industries will further boost the industry trends in the years ahead.
Lack of healthcare amenities and low availability of advanced Pyrogen testing devices, however, is anticipated to obstruct the Pyrogen testing market growth over the forthcoming years. Nevertheless, the increase in the number of outsourcing activities observed across the pharmaceutical sector is projected to generate a profitable roadmap for the Pyrogen testing industry over the ensuing years, normalizing the impact of hindrances on the Pyrogen testing market.
Report Attribute | Details |
---|---|
Base Year | 2022 |
Historic Years | 2018 - 2022 |
Forecast Years | 2023 - 2030 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2023 to 2030 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
On the basis of Product, the global gas market is segmented into Instruments, Services, and Kits and Reagents. The kits and Reagents market segment held the largest market share due to huge demand across the globe.
On the basis of Tests, the Pyrogen Testing market is segmented into In Vitro, LAL tests, and rabbits. The LAL Test segment is estimated to account for the largest Pyrogen Testing market share among all the Tests. This is attributed to the rapid growth in the pharmaceutical and biotechnology industries, increasing demand for medical devices, increasing health standards, rising need for innovative laboratory testing procedures, and the growing drug pipelines.
On the basis of Application, the Pyrogen Testing market is segmented into Pharmaceutical & Biotechnology, Medical Devices, and Others. The pharmaceutical & Biotechnology segment held the largest market share due to huge demand across the globe for the growth of the Pyrogen Testing market.
North America has been leading the worldwide Pyrogen testing market and is anticipated to continue in the dominant position in the years to come, states the Pyrogen testing market study. The presence of a well-established medical and healthcare infrastructure and skilled healthcare professionals has played a vital role in the dominance of the North America Pyrogen testing market. The high number of market players headquartered in North America is another significant factor that is supporting this regional Pyrogen testing market.
The major players operating in the Pyrogen Testing market are Thermo Fisher Scientific, Inc., Associates of Cape Cod, Inc., Charles River Laboratories, Inc., Ellab A/S, Genscript, Hyglos GmbH, Lonza Group, Merck Kgaa, WUXI Pharmatech (Cayman) Inc. and Wako Chemicals Usa, Inc.
The global Pyrogen Testing market is segmented as follows:
FrequentlyAsked Questions
The global Pyrogen Testing market was valued at USD 785.2 Million in 2020.
The global Pyrogen Testing market is expected to reach USD 2,008.4 Million by 2028, growing at a CAGR of 12.4% between 2021 to 2028.
Major driving factors for the growth of Pyrogen Testing market are Introduction of new drugs and rise in the R&D activities witnessed across pharmaceutical and biotech sectors.
North America has been leading the worldwide Pyrogen testing market and is anticipated to continue on the dominant position in the years to come, states the Pyrogen testing market study. The presence of a well-established medical and healthcare infrastructure and skilled healthcare professionals has played a vital role behind the dominance of the North America Pyrogen testing market.
The major players operating in the Pyrogen Testing market are Thermo Fisher Scientific, Inc., Associates of Cape Cod, Inc., Charles River Laboratories, Inc., Ellab A/S, Genscript, Hyglos GmbH, Lonza Group, Merck Kgaa, WUXI Pharmatech (Cayman) Inc. and Wako Chemicals Usa, Inc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed